Antidepressants for anxiety disorders in late-life: A systematic review.
Balasubramaniam M, Joshi P, Alag P, Gupta S, Maher S, Tampi D, Gupta A, Young J, Tampi RR. Antidepressants for anxiety disorders in late-life: A systematic review. Annals Of Clinical Psychiatry 2019, 31: 277-291. PMID: 31369663.Peer-Reviewed Educational MaterialsConceptsLate-life anxietyAnxiety disordersRCTs of antidepressantsCochrane Central RegisterTolerability of antidepressantsBibliographic databases PubMedGeneralized anxiety disorderLong-term useCentral RegisterControlled TrialsAntidepressantsElectronic searchDatabases PubMedSystematic reviewOlder adultsStudy periodTrialsDisordersAnxiety symptomsLater lifeLimited dataSignificant reductionAnxietyReviewTolerabilityANTIDEPRESSANTS FOR ANXIETY DISORDERS IN LATE-LIFE: A SYSTEMATIC REVIEW
Balasubramaniam M, Joshi P, Alag P, Gupta S, Maher S, Tampi D, Gupta A, Young J, Tampi R. ANTIDEPRESSANTS FOR ANXIETY DISORDERS IN LATE-LIFE: A SYSTEMATIC REVIEW. American Journal Of Geriatric Psychiatry 2019, 27: s125. DOI: 10.1016/j.jagp.2019.01.076.Peer-Reviewed Original ResearchSerotonin-norepinephrine reuptake inhibitorsSelective serotonin reuptake inhibitorsUse of antidepressantsTolerability of antidepressantsLate-life anxietySystematic reviewAnxiety disordersOlder adultsReuptake inhibitorsTreatment optionsTricyclic antidepressantsCognitive impairmentFirst-line pharmacological treatmentLate-life anxiety disordersVariable drug absorptionLong-term tolerabilityEfficacy of antidepressantsEfficacious treatment optionSerotonin reuptake inhibitorsPrevention of relapseCochrane Collaboration databasesTrial of paroxetineLate-life GADLater lifeVolume of distribution